PureTech Health (PRTC) Other Accumulated Expenses (2020 - 2025)
PureTech Health (PRTC) reported Other Accumulated Expenses of $4.8 million for Q4 2025, up 31.14% year-over-year from $3.7 million in Q4 2024, and up 31.14% quarter-over-quarter from $3.7 million in Q4 2024.
PureTech Health (PRTC) Other Accumulated Expenses (2020 - 2025) Analysis & Trends
PureTech Health (PRTC) has 6 years of Other Accumulated Expenses data on file, last reported at $4.8 million in Q4 2025.
- Other Accumulated Expenses for Q4 2025 came in at $4.8 million, up 31.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.8 million (up 31.14% YoY), and the FY2025 annual result was $4.8 million, up 31.14% from the prior year.
- Other Accumulated Expenses climbed to $4.8 million in Q4 2025 per PRTC's latest filing, from $3.7 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $12.4 million in Q4 2022 and troughed at $3.4 million in Q4 2023.
- A 5-year average of $5.8 million and a median of $4.8 million in 2025 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses surged 150.78% in 2022, then sank 72.54% in 2023.
- A 5-year view of Other Accumulated Expenses shows it stood at $4.9 million in 2021, then soared by 150.78% to $12.4 million in 2022, then slumped by 72.54% to $3.4 million in 2023, then increased by 7.66% to $3.7 million in 2024, then surged by 31.14% to $4.8 million in 2025.
- Business Quant data shows PRTC's Other Accumulated Expenses at $4.8 million in Q4 2025, $3.7 million in Q4 2024, and $3.4 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.79 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Dec 31, 2023 | 3.39 Mn |
| Dec 31, 2022 | 12.36 Mn |
| Dec 31, 2021 | 4.93 Mn |
| Dec 31, 2020 | 6.72 Mn |